Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
26/06/2008 | 23:39 | Business Wire | Bristol-Myers Squibb Completes Acquisition of Kosan Biosciences Incorporated | NASDAQ:KOSN | Kosan Biosciences (MM) |
26/06/2008 | 22:34 | Edgar (US Regulatory) | Kosan Biosciences Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G) | NASDAQ:KOSN | Kosan Biosciences (MM) |
26/06/2008 | 22:20 | Edgar (US Regulatory) | Kosan Biosciences Inc- (25-NSE) | NASDAQ:KOSN | Kosan Biosciences (MM) |
26/06/2008 | 19:36 | Edgar (US Regulatory) | Kosan Biosciences Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:KOSN | Kosan Biosciences (MM) |
26/06/2008 | 16:08 | Edgar (US Regulatory) | Kosan Biosciences Inc - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:KOSN | Kosan Biosciences (MM) |
03/06/2008 | 16:00 | PR Newswire (US) | Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breas | NASDAQ:KOSN | Kosan Biosciences (MM) |
30/05/2008 | 15:33 | Marketwired | Wall Street News Alert: Stocks on the Move for Friday: CPYE! May 30, 2008 | NASDAQ:KOSN | Kosan Biosciences (MM) |
30/05/2008 | 13:15 | Marketwired | Equity Spotlight for Friday, May 30, 2008: MDII Additional Product Order! | NASDAQ:KOSN | Kosan Biosciences (MM) |
29/05/2008 | 22:36 | Edgar (US Regulatory) | Kosan Biosciences Inc - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:KOSN | Kosan Biosciences (MM) |
29/05/2008 | 22:23 | Edgar (US Regulatory) | Kosan Biosciences Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:KOSN | Kosan Biosciences (MM) |
29/05/2008 | 20:20 | Business Wire | Bristol-Myers Squibb Begins Tender Offer to Acquire Kosan Biosciences Inc. | NASDAQ:KOSN | Kosan Biosciences (MM) |
29/05/2008 | 19:30 | Edgar (US Regulatory) | Kosan Biosciences Inc - Tender offer statement by Third Party (SC TO-T) | NASDAQ:KOSN | Kosan Biosciences (MM) |
29/05/2008 | 18:32 | Edgar (US Regulatory) | Kosan Biosciences Inc - Current report filing (8-K) | NASDAQ:KOSN | Kosan Biosciences (MM) |
29/05/2008 | 17:06 | Marketwired | BellwetherReport.com Analyst Report on KOSN, ACEL, SHLD and SSCC | NASDAQ:KOSN | Kosan Biosciences (MM) |
29/05/2008 | 14:22 | Business Wire | Bristol-Myers Squibb to Acquire Kosan Biosciences | NASDAQ:KOSN | Kosan Biosciences (MM) |
28/05/2008 | 19:27 | Edgar (US Regulatory) | Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:KOSN | Kosan Biosciences (MM) |
20/05/2008 | 12:00 | PR Newswire (US) | Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer | NASDAQ:KOSN | Kosan Biosciences (MM) |
14/05/2008 | 12:00 | PR Newswire (US) | Kosan Announces Data Presentations at ASCO 2008 Annual Meeting | NASDAQ:KOSN | Kosan Biosciences (MM) |
12/05/2008 | 22:52 | Edgar (US Regulatory) | Kosan Biosciences Inc - Quarterly Report (10-Q) | NASDAQ:KOSN | Kosan Biosciences (MM) |
06/05/2008 | 22:00 | PR Newswire (US) | Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference | NASDAQ:KOSN | Kosan Biosciences (MM) |
01/05/2008 | 23:00 | PR Newswire (US) | Kosan Announces First Quarter 2008 Financial Results | NASDAQ:KOSN | Kosan Biosciences (MM) |
25/04/2008 | 13:00 | PR Newswire (US) | Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results | NASDAQ:KOSN | Kosan Biosciences (MM) |
24/04/2008 | 12:08 | Edgar (US Regulatory) | Kosan Biosciences Inc - Proxy Statement (definitive) (DEF 14A) | NASDAQ:KOSN | Kosan Biosciences (MM) |
16/04/2008 | 23:09 | PR Newswire (US) | Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR | NASDAQ:KOSN | Kosan Biosciences (MM) |
16/04/2008 | 23:06 | PR Newswire (US) | Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR | NASDAQ:KOSN | Kosan Biosciences (MM) |
14/04/2008 | 13:00 | PR Newswire (US) | Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer | NASDAQ:KOSN | Kosan Biosciences (MM) |
28/03/2008 | 20:13 | Edgar (US Regulatory) | Kosan Biosciences Inc - Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:KOSN | Kosan Biosciences (MM) |
18/03/2008 | 23:45 | PR Newswire (US) | Kosan Restructures Workforce to Focus Resources on Lead Clinical Programs | NASDAQ:KOSN | Kosan Biosciences (MM) |
18/03/2008 | 21:00 | PR Newswire (US) | Kosan's Board of Directors Appoints Helen S. Kim as Chief Executive Officer | NASDAQ:KOSN | Kosan Biosciences (MM) |
17/03/2008 | 21:53 | Edgar (US Regulatory) | Kosan Biosciences Inc - Annual Report (10-K) | NASDAQ:KOSN | Kosan Biosciences (MM) |